
Hey there, it's Vadim 👋
Before we dive in, I have some exciting news:
Next Sunday, Bio Founder GPS turns one! 🎉
Before I write the anniversary issue, I'd love your honest take on what you take away from this newsletter and how GPS can be even better.
I put together a super quick survey with a few questions, and it should take no more than 2-3 min to complete. It would be amazing to get your feedback!
As my small way of saying “thank you”, everyone who responds to the survey by this Thursday, Oct 22nd, will get the upcoming refreshed Family Office Report first, before it goes public.
I have a LOT of ideas for year two, so your answers will decide what comes first. Let’s build this together 🙂
Now, let’s chat about JPM.
Back in July, I described biotech fundraising as having seasons. Fall is the harvest window, from September through mid-November, and winter is the reset, when JPM pulls the whole industry back into motion.
We're now in the back half of that harvest window, and the reset is a lot closer than it may look.
The 45th JPM Healthcare Conference opens in San Francisco on Monday, January 11th. That's exactly 12 weeks from tomorrow.
Most of us won't be inside the main conference, which is invitation-only, and that's completely fine. JPM still sets our calendars, because it sets our investors' calendars: who's traveling, who's taking meetings, and when the first serious conversations of 2027 happen.
So today, I’d like to work backwards from that Monday and answer one question:
If your most important investor meeting of Q1 happens the week of January 11, what has to be true by Thanksgiving, and what do you need to start this week?
Here's the whole calendar at a glance 👇
Date | What happens |
|---|---|
Fri, Oct 23 | RESI JPM super early bird pricing ends |
Wed, Nov 11 | RESI JPM pitch challenge applications close |
Fri, Nov 13 | Biotech Showcase early pricing ends |
Tue, Nov 24 | Biotech Showcase partnering opens |
Wed, Nov 25 | Your materials and target list are done |
Mon, Nov 30 | Your first wave of outreach goes out |
Mid-December | Most JPM schedules are set |
Fri, Dec 18 | Your JPM calendar is locked |
Jan 11-14 | JPM week |
Let's walk through it backwards, starting in January 👇
Meet this week’s sponsor (hint: it’s me 🙂)
If you missed it, yesterday I introduced Bio Founder Raise, the tool I've been building behind the scenes to help life science founders run their raise and stay on top of investor and competitor activity in their space.
Most founders I talk to are raising with a spreadsheet, investor names of questionable quality, and follow-ups scattered across their inbox.
The tools that could help are either built (and priced) for enterprise teams, not focused on life sciences - or both.
So I built what I wish I had when I was fundraising and something I could use when I’m working with my clients.
Raise reviews your pitch deck, finds the right funds and people to contact, shows you who’s actually been investing in your field, and keeps your outreach on track so nothing falls through the cracks.
And that’s just the start. The goal is for Raise to become a 24/7 Chief Business Officer in your corner, so you can run your raise without your raise running you.
What’s inside so far: 2,000+ verified life science funds, 4,600+ partners and team members across about 700 US funds, and data on 2,000+ pre-seed through Series A rounds since 2023.
It's in private beta right now, and over the next few weeks I'll start opening it up in small waves, first come, first served.
If this sounds like it may be helpful, I encourage you to secure your spot on the waitlist.
JANUARY 11
Your JPM week gets decided in December
T-0: what a good JPM week looks like when you're early
For an early-stage founder, JPM week mostly happens outside the main conference. It happens at the partnering forums, pitch events, receptions and coffee meetings that fill the city around it (and every hotel lobby within a ten-minute radius 🙂).
Some of those forums are getting big. Biotech Showcase alone hosted 2,800 attendees last January, including over a thousand investors, and logged over 5,000 meetings. RESI JPM and BIO Partnering @JPM Week run their own partnering systems the same week.
That's a lot of opportunity, but also a lot of noise. So the first thing I'd do is decide which JPM you're actually going to, because there are actually three parallel tracks.
The fundraising JPM: you're there for first or second meetings with investors who could lead or anchor your round. You’re in the final stretch with your dream investors, and your materials need to hold up to diligence questions that same week.
The partnering JPM: you're there for pharma BD. Early pharma conversations are very different from investor pitches: the goal is to learn what a partner would need to see, not to close anything. And if this is your JPM, you're already on the clock. I suggest starting your outreach as early as September, because those calendars get planned months ahead.
The relationship JPM: you're raising later in 2027, and this week is about meeting the people you'll want to know when you do. It's lower pressure, but it still needs a method to the madness.
You can do more than one, but it's very hard to do all three well in just four days.
And if you're not going at all, the week still matters. Your investors will be traveling, and their inboxes will be packed, so I wouldn't launch a new outreach wave in the first two weeks of January. The weeks right after JPM are when the follow-ups and the Q1 processes actually start moving.
My advice:
Pick your JPM: decide for yourself whether you're raising, partnering, or building relationships, and let that drive who goes on your list.
Count the meetings you ACTUALLY need: five meetings with likely leads will do more for your round than twenty-five coffees with people who can't write a check.
Treat JPM as a part of the raise, not the raise itself: most of your meetings will still happen in the weeks after it.
NOVEMBER 30
The booking window is shorter than most realize
T minus 4-6 weeks: when JPM meetings actually get booked
If you’re on the fundraising track, keep in mind: the meetings get booked in a short window, well in advance.
I’d start reaching out to specialist investors in late November or early December, once they're back from Thanksgiving. By then, investors know whether they're attending, and they're about two weeks away from finalizing their schedules.
Biotech Showcase runs on a similar clock. Its partnering platform opens on November 24, and accepted meetings start getting scheduled the next day.
Put those together, and most JPM calendars get set between November 30 and mid-December. After that, the holidays take over.
That gives you about three working weeks. You can’t write a thoughtful email to 300 investors in that time, but the good news is - you don’t have to.
Use December for the 20 or so investors you’d most love to have lead your round. Everyone else can wait until January, February, or March.
The step founders most often leave until it’s too late is warm intros. They run on someone else’s schedule, so if you ask in December, the investor’s calendar may be full by the time the connector follows up with them.
My advice:
Ask for intros the week of November 16: give each connector a ready-to-forward blurb, so they can get it to their contacts before the end of the month.
Draft your meeting requests before Thanksgiving: send them when everyone is back from Thanksgiving break so your outreach lands at the top of their inbox.
Follow up once, around December 7 or 8: a short, specific note works best here.
Treat December 18 as your lock date: whatever's on your calendar by then is the core of your JPM week.
NOVEMBER 25
Your real deadline is the day before Thanksgiving
T minus 7 weeks: everything an investor asks for in December has to exist in November
If your first wave goes out on November 30, then everything an interested investor might ask for in December needs to exist before you sit down for turkey.
That's just 5-6 weeks from now.
How do you know you’re ready to raise? At a simple level, it comes down to five things:
One consistent story: the deck, the one-pager and the intro blurb should lead with the same thing and describe the same round.
A first version of your data room: it doesn't need to be exhaustive, but the cap table, IP summary, key data and use of proceeds should be easy to find.
A tiered target investor list: every name has a tier and a “last checked” date.
Outreach that's already written: the meeting-request email and the forwardable intro blurb exist in a doc, not just in your head.
The round in one sentence: “This round funds X to prove Y by Z.” Work out the milestone and the money first, and the label (pre-seed, seed, seed extension) will follow.
My advice: do a dry run the week of November 16. Send everything to one friendly investor or advisor, note which questions come up and where you get stuck, and make those fixes before the main outreach.
OCTOBER 19
Run the 100-meeting math backwards
How to build your investor list
Which brings us to tomorrow.
There's a rule of thumb I use with founders that I call the 100-meeting math: closing an early-stage round often takes 100 or more investor meetings, and at a 20-30% conversion from outreach to meeting (if we’re optimistic), that means reaching out to 300-500 qualified investors over the course of the raise.
That number scares a lot of founders, so let's run it backwards too.
You don't need 500 verified investors by Thanksgiving. You need the top of the list, the 50 to 100 names your December outreach will actually go to, checked and tiered. If you verify about 20 names a week for the next five weeks, you'll have roughly 100 by November 20, with a few days to spare.
And verification matters more this season than it did a few years ago. In J.P. Morgan's own venture report for the first half of 2026, seed and Series A rounds raised $4.8B across 114 deals globally, while Series B and later rounds raised $11.5B across 121 deals. Later-stage rounds took 71% of venture dollars, up from 62% in 2025.
With fewer early checks to go around, every name on your December list has to be a real prospect. As we talked about in August, a list padded with funds that can't invest in your round doesn't just waste your time. It hands you a false read on your own company, right when you can least afford one.
My advice: for each of this week's 20 names, answer five questions:
Have they made a new investment in the last 12 months? A new company, not a follow-on. This is the most useful version of what I call the fresh capital signal: not just that a fund raised recently, but that it's actively putting that money to work.
Can this vehicle write a first check? Opportunity, growth and continuation funds usually can't, no matter how recently they closed.
Do they lead, or follow? You want at least a few possible leads in your main outreach.
Does their typical check fit your round? A fund that writes $10M checks won't anchor a $2M seed.
Is there a conflict, or an adjacent bet, in their portfolio? Sometimes that's a reason to skip them, but sometimes it means they'll get your science faster. The devil will be in the details, so do your homework first.
YOUR ACTION POINTS
Three things to do before next Sunday
Put the dates in your calendar: November 24 (Biotech Showcase partnering opens), November 25 (your materials and list are done), November 30 (your first wave goes out) and December 18 (your JPM calendar is locked).
Check your dream 20 investors: has each one made a new investment in the last 12 months? For now, move the ones that haven't to “warm up for later.”
Write your one sentence: “This round funds X to prove Y by Z.” If it doesn't come easily, you know what to focus on in Nov.
And so you don’t have to start from scratch, I put together a free JPM planner with all the key dates, events, and trackers in one place 👇
BONUS RESOURCES
Your JPM Week 2027 planner
JPM week is a lot more than one conference. Around it, there are dozens of partnering forums, pitch showcases, and receptions, and finding the ones worth your time is often a project in itself.
So I put together a free planner to help. It has five tabs:
Key dates: every deadline from now until January, next to the four dates from this issue.
Events: 30 partnering forums, pitch showcases, non-dilutive funding sessions, and receptions already confirmed for 2027, with costs, deadlines, who each one is for, and links. I've starred the best first stops for early-stage founders.
Watch list: events that ran in 2026 but haven't announced their 2027 dates yet.
Trackers and apps: where to find the side events and receptions as they get announced.
My JPM week: a simple tracker for your own meetings. Just copy it into your workspace, and you’re all set.
If you only do two things today:
Bookmark On Your Mark. Big4Bio's free guide is already live for 2027. You can filter by day and by access (open, registration, invite-only), and export events to your calendar. Sign up for its PDF editions too, because Big4Bio notes that roughly half of receptions get announced in the last four weeks.
Download bioRSVP. It's the free JPM Week events app from Novateur Ventures and BIO, and its 2027 list gets published in late December. During the week itself, it's the easiest way to keep track of evening events from your phone.
Additional resources to keep in mind:
If you've raised $2M or less, Biotech Showcase has a Seed Showcase track for companies founded in the last three years with fewer than five employees. It's $2,225 if you register before November 13.
Forward your investors registration links: Biotech Showcase, BIO Partnering @JPM Week and RESI JPM let qualified investors register for free, so send those pages to the investors you'd most like to see there - especially emerging fund managers. Whether or not they already signed up, it can be a nice way to show you’re thinking of them 😉
THAT'S A WRAP!
In fundraising, as in many parts of life, an imperfectly executed plan beats having no plan at all.
A good JPM week usually starts in November, with a list you’ve actually checked and materials and emails ready to go.
But if you’ve been to a few conferences, you know how much of it also comes down to serendipity. The connection you make while waiting in line at Starbucks can end up more fruitful than the meeting you spent months preparing for.
Does that mean you should just wing it? Not quite. As they say, luck favors the prepared.
So do the work in November, then give yourself some breathing room in January: a few open slots on the calendar, an open mind, and maybe even (dare I say it) a bit of fun 🙂
Your homework this week: fill out your calendar, identify your dream 20 investors, and reply to tell me which events you’re planning to attend. I’m making my schedule as well, and would love to cross paths!
See you next Sunday, for our first birthday!! 🎉🕺🏻
- Vadim
PS: When are you raising? Click below so I know what to send you over the next few weeks 👇
When are you planning to raise?
PPS: If you're raising now or in Q1 and want a second pair of eyes on your JPM plan, I'm opening up my calendar between now and Thanksgiving for short 20-minute calls. Bring your target list and your one-sentence blurb, and we'll pressure-test the plan together.
